Pharmacokinetic Drug-Drug Interaction
Showing 1 - 25 of >10,000
Interaction, Endogenous Biomarkers Trial in Spokane (MetFORMIN Oral Solution, Cimetidine 400 MG, Furosemide Oral Liquid Product)
Recruiting
- Interaction
- Endogenous Biomarkers
- MetFORMIN Oral Solution
- +3 more
-
Spokane, WashingtonWashington State University College of Pharmacy and Pharmaceutic
Sep 8, 2022
Healthy Trial in Mardan (Voriconazole 200 mg x 2 Tablets, Clarithromycin 500 mg x 1Tablets)
Completed
- Healthy
- Voriconazole 200 mg x 2 Tablets
- Clarithromycin 500 mg x 1Tablets
-
Mardan, KPK, PakistanMedical Dispensary, Abdul Wali Khan University Mardan, Pakistan.
May 14, 2022
Healthy Participants Trial in Groningen (AB521, Placebo, Midazolam)
Recruiting
- Healthy Participants
- AB521
- +2 more
-
Groningen, NetherlandsInvestigational Site
Dec 6, 2022
Drug-drug Interaction Trial in Seoul (DWC202211 100mg, DWC202212 5mg, DWC202211 100mg + DWC202212 5mg)
Not yet recruiting
- Drug-drug Interaction
- DWC202211 100mg
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 24, 2023
Drug Interaction Trial in Ile-Ife (Nitazoxanide, "Nitazoxanide" and "atazanavir/ritonavir" separately)
Active, not recruiting
- Drug Interaction
- Nitazoxanide
- "Nitazoxanide" and "atazanavir/ritonavir" separately
-
Ile-Ife, Osun, NigeriaObafemi Awolowo University
Jan 8, 2023
Healthy Subjects Trial in Qingdao (XZP-3621 tablet and itraconazole oral liquid (for Arm1), XZP-3621 tablet and Rifampicin
Not yet recruiting
- Healthy Subjects
- XZP-3621 tablet and itraconazole oral liquid (for Arm1)
- +2 more
-
Qingdao, Shan Dong, ChinaThe Affiliated Hospital of Qingdao University
Oct 16, 2022
Interaction, Adverse Herb-Drug, Diabetes, Type 2 Trial in Spokane (Midazolam Hcl 1Mg/Ml Inj, Goldenseal (Hydrastis canadensis))
Active, not recruiting
- Interaction, Adverse Herb-Drug
- Diabetes Mellitus, Type 2
- Midazolam Hcl 1Mg/Ml Inj
- Goldenseal (Hydrastis canadensis)
-
Spokane, WashingtonWashington State University College of Pharmacy and Pharmaceutic
Nov 18, 2022
Drug Drug Interaction Trial in Chengdu (SPH3127 tablet, Itraconazole, Rifampin)
Completed
- Drug Drug Interaction
- SPH3127 tablet
- +2 more
-
Chengdu, Sichuan, ChinaWest China Second University Hospital, Sichuan University
Jul 28, 2022
Drug Interaction Potentiation Trial in Seoul (Ilaprazole, Aceclofenac)
Not yet recruiting
- Drug Interaction Potentiation
-
Seoul, Korea, Republic ofSeverance Hospital
Sep 23, 2022
Healthy Participants Trial (pyrotinib maleate, Loperamide)
Completed
- Healthy Participants
- pyrotinib maleate
- Loperamide
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Oct 27, 2022
Healthy Trial in Jeonju (Treatment A, Treatment B, Treatment C)
Completed
- Healthy
- Treatment A
- +4 more
-
Jeonju, Jeollabuk-do, Korea, Republic ofJeonbuk National University Hospita
Jul 18, 2022
Drug Interaction Potentiation Trial in Seoul (Ilaprazole, Naproxen, Aceclofenac)
Recruiting
- Drug Interaction Potentiation
- Ilaprazole
- +3 more
-
Seoul, Korea, Republic ofSeverance Hospital
Aug 7, 2022
Determining Clinical Relevance of Interaction Between
Recruiting
- Drug-drug Interaction
- Blood sampling - Pharmacokinetic assessment
-
Nijmegen, Netherlands
- +2 more
Oct 26, 2022
Rheumatoid Arthritis Trial in Wuhan (SHR0302 Tablets, Midazolam Maleate Tablets, Warfarin Sodium Tablets)
Completed
- Rheumatoid Arthritis
- SHR0302 Tablets
- +5 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Dec 21, 2022
Trypanosomiasis, African Trial in Kuala Lumpur (Acoziborole, Midazolam, Dextromethorphan)
Completed
- Trypanosomiasis, African
- Acoziborole
- +2 more
-
Kuala Lumpur, MalaysiaClinical Research Center (CRC) Ampang Hospital
Jul 7, 2023
Healthy Volunteers Trial in Changchun (Larotinib, Rifampin, Itraconazole)
Active, not recruiting
- Healthy Volunteers
- Larotinib
- +2 more
-
Changchun, Jilin, ChinaFirst Hospital of Jilin University
Oct 26, 2022
Drug Drug Interaction Trial in Glendale (AV-101, Probenecid)
Recruiting
- Drug Drug Interaction
-
Glendale, CaliforniaParexel Early Phase Clinical Unit
Mar 3, 2022
Health, Subjective Trial in Seoul (Drug: Treatment A, Drug: Treatment B, Drug: Treatment C)
Completed
- Health, Subjective
- Drug: Treatment A
- +2 more
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Dec 21, 2021
Type 2 Diabetes Trial in Seoul (Teneligliptin, Empagliflozin, Teneligliptin and Empagliflozin)
Completed
- Type 2 Diabetes Mellitus
- Teneligliptin
- +2 more
-
Seoul, Korea, Republic ofClinical Pharmacology, Asan Medical Center
Nov 8, 2021
Drug-drug Interaction Trial in Guangzhou (ZSP1273, Oseltamivir)
Completed
- Drug-drug Interaction
-
Guangzhou, Guangdong, ChinaGuangdong Provincial Hospital of Chinese Medicine
Oct 24, 2021
Drug-drug Interactions Between Hormonal Contraceptives and
Recruiting
- HIV Infections
- +2 more
- Etonogestrel (ETG) implant
- +3 more
-
Johannesburg, South AfricaWits Reproductive Health and HIV Institute, Research Centre Clin
Feb 28, 2022
Chronic Hepatitis B Trial in Changchun (GLS4, RTV, TAF)
Completed
- Chronic Hepatitis B
- GLS4
- +2 more
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
May 20, 2022